Sorry but this is classic data cherry picking. BTW there was nothing in the trial design mentioning high concentration vs. low concentration cisplatin.
We still don’t know how some drugs work, but they were approved despite making little to no scientific or physiological sense. Our body is too complex to be understood for everything.
If B-OM is proven to safe and efficacious in certain pateint population, the FDA will approve it. The physician will prescirbe B-OM for the same population if it’s the best treatment available.
The q-3wk seems to have strong signal, but the flip side of that coin is that the q-1wk is no signal at all, and together make little physiological sense.